Verona Pharma Plc - ADR
VRNA
Market Cap$816.14M
Close$
$3.49
76.6% downside
Current Fair Value
76.6% downsideOvervalued by 76.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $816.14 Million |
|---|---|
| Enterprise Value | $579.07 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.08 |
| Beta | 1.05 |
| Outstanding Shares | 51,818,199 |
| Avg 30 Day Volume | 450,581 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -16.1 |
|---|---|
| PEG | 262.43 |
| Price to Sales | - |
| Price to Book Ratio | 2.98 |
| Enterprise Value to Revenue | 1264.35 |
| Enterprise Value to EBIT | -9.24 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
ESG Score
No data
About Verona Pharma Plc
CEO: David Zaccardelli